A novel peptide interferes with Mycobacterium tuberculosis virulence and survival

Tuberculosis (TB) is a huge global burden, with new and resistant strains emerging at an alarming rate, necessitating an urgent need for a new class of drug candidates. Here, we report that SL3, a novel 33-amino acid peptide, causes debilitating effects on mycobacterial morphology. Treatment with SL...

Descripción completa

Detalles Bibliográficos
Autores principales: Samuchiwal, Sachin Kumar, Tousif, Sultan, Singh, Dhiraj Kumar, Kumar, Arun, Ghosh, Anamika, Bhalla, Kuhulika, Prakash, Prem, Kumar, Sushil, Trivedi, Ashish Chandra, Bhattacharyya, Maitree, Das, Gobardhan, Ranganathan, Anand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4208091/
https://www.ncbi.nlm.nih.gov/pubmed/25349777
http://dx.doi.org/10.1016/j.fob.2014.08.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4208091/
https://www.ncbi.nlm.nih.gov/pubmed/25349777
http://dx.doi.org/10.1016/j.fob.2014.08.001

Ejemplares similares